Relationships of hepatic and pancreatic biomarkers with the cholestatic syndrome and tumor stage in pancreatic cancer

Author： Porta Miquel   Pumarega José   Guarner Luisa   Malats Núria   Solà Ricard   Real Francisco X.    

Publisher： Informa Healthcare

ISSN： 1366-5804

Source： Biomarkers, Vol.17, Iss.6, 2012-09, pp. : 557-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Role of Proteomics in Pancreatic Cancer Biomarkers Research

By  

Current Proteomics, Vol. 13, Iss. 1, 2016-03 ,pp. : 68-75

Bentham Science Publishers

Access to resources Recommend Favorite

Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer

By Morse Michael A   Hall Joseph Robert   Plate Janet MD  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 3, 2009-03 ,pp. : 331-339

Informa Healthcare

Access to resources Recommend Favorite

Troxacitabine Prodrugs for Pancreatic Cancer

By Adema A. D.   Radi M.   Daft J.   Narayanasamy J.   Hoebe E. K.   Alexander L. E.   Chu C. K.   Peters G. J.  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 8-9, 2007-08 ,pp. : 1073-1077

Taylor & Francis Ltd

Access to resources Recommend Favorite

Biotherapeutic approaches to pancreatic cancer

By Rosenberg Lawrence   Lipsett Mark  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 319-337

Informa Healthcare

Access to resources Recommend Favorite

Her signaling in pancreatic cancer

By Burtness Barbara  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 823-829

Informa Healthcare

Access to resources Recommend Favorite